13 September 2022 | The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
| Stolbrink, M; Thomson, H; Hadfield, RM; et al. |
1 March 2023 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD executive summary
| Agustí, A; Celli, BR; Criner, GJ; et al. |
1 April 2023 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD executive summary
| Agustí, A; Celli, BR; Criner, GJ; et al. |
1 April 2023 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD executive summary
| Agustí, A; Celli, BR; Criner, GJ; et al. |
1 March 2023 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD executive summary
| Agustí, A; Celli, BR; Criner, GJ; et al. |
1 April 2023 | Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD executive summary
| Agustí, A; Celli, BR; Criner, GJ; et al. |
1 November 2022 | Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries.
| Stolbrink, M; Chinouya, MJ; Jayasooriya, S; et al. |